RSV vaccine candidate

BIOLOGICAL2 trials

Sponsors

Sanofi Pasteur, a Sanofi Company

Conditions

Healthy VolunteersRespiratory Syncytial Virus ImmunizationRespiratory Syncytial Virus Infection

Phase 1

Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and Older

CompletedNCT05639894

Sanofi Pasteur, a Sanofi CompanyRespiratory Syncytial Virus Immunization

Start: 2022-11-17End: 2025-05-02Updated: 2026-08-05

Phase 2

Study of a Respiratory Syncytial Virus Candidate Formulation in Adults Aged 60 Years and Older

CompletedNCT06251024

Sanofi Pasteur, a Sanofi CompanyHealthy Volunteers, Respiratory Syncytial Virus Infection

Start: 2024-04-02End: 2025-03-11Updated: 2026-03-10